The Framingham Predictive Instrument in Chronic Kidney Disease
Daniel E. Weiner, MD, MS*,*,
Hocine Tighiouart, MS ,
Essam F. Elsayed, MD*,
John L. Griffith, PhD,
Deeb N. Salem, MD, FACC ,
Andrew S. Levey, MD* and
Mark J. Sarnak, MD, MS*
* Division of Nephrology
Division of Clinical Care Research
Division of Cardiology, Tufts-New England Medical Center, Boston, Massachusetts
View larger version (26K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Predicted and Actual 5-Year Risk of Cardiac Events
Graphical presentation of actual 5-year risk of cardiac outcomes in men with chronic kidney disease along with predicted risk, with and without recalibration for higher event rates in chronic kidney disease stratified by quintile of predicted Framingham risk.
|
|
View larger version (24K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Predicted and Actual 10-Year Risk of Cardiac Events
Graphical presentation of actual 10-year risk of cardiac outcomes in women with chronic kidney disease along with predicted risk, with and without recalibration for higher event rates in chronic kidney disease stratified by quintile of predicted Framingham risk.
|
|
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3 Cardiac and Mortality Event Rates
Actual 5- and 10-year composite outcomes (consisting of cardiac outcomes and all-cause mortality) stratified by quintile of predicted Framingham risk.
|
|
|
